| Product Name | MF | CAS | Details |
|---|
| Gymnemagenin | C30H50O6 | 22467-07-8 | Details |
| tert-Butyl N-[(1S,3S)-3-cyanocyclobutyl]carbamate | C10H16N2O2 | 2230789-54-3 | Details |
| P2RXL1 Blocking Peptide | Details |
| N-Tosylpalmitamide | Details |
| 1-((1-(Allyloxy)propan-2-yl)oxy)propan-2-ol | C9H18O3 | 55956-25-7 | Details |
| Betrixaban - Bio-X ? | C23H22ClN5O3 | 330942-05-7 | Details |
| 6-benzo[d]1,3-dioxolan-5-yl-3-(4-chlorophenyl)-4-imino-1,3,7-trihydro-5,7-diazaquinazoline-2,8-dione | C19H12ClN5O4 | 379707-99-0 | Details |
| 1,6-Hexanediol diglycidylether | C12H22O4 | 16096-31-4 | Details |
| 3-Methoxypropane-1,2-diamine | C4H12N2O | 101857-37-8 | Details |
| Ethyl(oxolan-3-ylmethyl)amine | C7H15NO | 165253-30-5 | Details |
| KZR-616 | C30H42N4O8 | 1629677-75-3 | Details |
| 1-[5-(4-Chlorophenyl)-1,2,4-oxadiazol-3-yl]methanamine hydrochloride | C9H9Cl2N3O | 1179370-94-5 | Details |
| 3-Bromo-2-chlorothiophene-5-sulphonyl chloride | C4HBrCl2O2S2 | 166964-35-8 | Details |
| 2-(Methanesulfonylmethyl)aniline | C8H11NO2S | 25195-69-1 | Details |
| beta-Casomorphin (1-2) | C14H18N2O4 | 51871-47-7 | Details |
| 2-Bromoethyl N-phenylcarbamate | C9H10BrNO2 | 32353-12-1 | Details |
| CNOT1 antibody | Details |
| 1-(Pyridin-3-ylmethyl)piperidin-4-one | C11H14N2O | 41661-57-8 | Details |
| 3'-Sulpho Lewis X-BSA | Details |
| Rest Blocking Peptide | Details |
| 1-bromo-2-(prop-1-en-2-yl)benzene | C9H9Br | 7073-70-3 | Details |
| Alloalantolactone | C15H20O2 | 64340-41-6 | Details |
| PF-06737007 | C25H28F4N2O6 | 1863905-38-7 | Details |
| L-Kynurenine sulfate salt | C10H16N2O8S | 16055-80-4 | Details |
| N-Acetylnorloline | C9H14N2O2 | 38964-35-1 | Details |
| 1-(6-Aminopyridin-3-yl)pyrrolidin-2-one | C9H11N3O | 866620-34-0 | Details |
| 3-Bromo-6,8-dichloroimidazo[1,2-a]pyrazine | C6H2BrCl2N3 | 1379351-34-4 | Details |
| (5E)-2,2-Dimethyl-7-[(1-naphthalenylmethyl)amino]-5-hepten-3-ynoic acid | C20H21NO2 | 99473-15-1 | Details |
| Thionicotinamide | C6H6N2S | 4621-66-3 | Details |
| IKZF2 antibody | Details |
| 4-Methyl-1H-1,2,3-benzotriazole | C7H7N3 | 29878-31-7 | Details |
| 4-Chloro-3-nitrobenzenethiol | C6H4ClNO2S | 100191-28-4 | Details |
| Eriocalyxin B | C20H24O5 | 84745-95-9 | Details |
| 2-(Phenylamino)propanenitrile | C9H10N2 | 2182-39-0 | Details |
| 4-Methoxy-3-nitrobenzoic acid methyl ester | C9H9NO5 | 40757-20-8 | Details |
| Resorufin sodium salt - 95% | C12H6NNaO3 | 34994-50-8 | Details |
| Dimethyl({2-[2-(piperazin-1-yl)phenoxy]ethyl})amine | C14H23N3O | 444606-74-0 | Details |
| H-VLGSGAFGTVYK-OH | Details |
| Bromo-PEG2-bromide | C6H12Br2O2 | 31255-10-4 | Details |
| RAD51 antibody | Details |
| 3-[4-(2-Methoxyethyl)phenoxy]-1,2-epoxypropane | C12H16O3 | 56718-70-8 | Details |
| Apolipoprotein E N-term Heavy Tryptic Peptide Standard (4nmol) | Details |
| Exendin-4 (1-8) trifluoroacetate salt | C35H51N11O13 | 1802078-29-0 | Details |
| 3-Bromo-1-methylpyridin-4(1H)-one | C6H6BrNO | 87875-76-1 | Details |
| 2,2'-Bipyridine-5,5'-dicarboxylic acid | C12H8N2O4 | 1802-30-8 | Details |
| PRND antibody | Details |
| H-ASSIIDELFQDR-OH | Details |
| H-SLYNTIAVL-OH | Details |
| 1-Chloro-3-(iodomethyl)benzene | C7H6ClI | 70450-41-8 | Details |
| 3-Amino-2-(o-tolyl)quinazolin-4(3H)-one | C15H13N3O | 63002-69-7 | Details |
| Nor-6α-oxycodol | C17H21NO4 | 116499-16-2 | Details |
| 2-Propylpiperidine hydrochloride | C8H18ClN | 15991-59-0 | Details |
| HIV1-RT antibody | Details |
| H-APEPVEIR-OH | Details |
| 4-Ethyl-5-(4-nitrophenyl)-4H-1,2,4-triazole-3-thiol | C10H10N4O2S | 29527-36-4 | Details |
| 2,2,2-Trifluoroethyl N-(3,5-dichlorophenyl)carbamate | C9H6Cl2F3NO2 | 1087788-79-1 | Details |
| tert-Butyl 3-[1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-3-yl]morpholine-4-carboxylate | C13H19F3N4O3 | 1803586-70-0 | Details |
| PARP6 antibody | Details |
| 2-(4-tert-Butylcyclohexylidene)acetic acid | C12H20O2 | 13733-51-2 | Details |
| 2-naphthyl-1-(4-(2-pyridyl)piperazinyl)ethan-1-one | C21H21N3O | 924214-12-0 | Details |
| 2-(Pyrrolidin-3-yl)-1,3-thiazole-4-carboxylic acid hydrochloride | C8H11ClN2O2S | 2243513-22-4 | Details |
| KIAA0776 antibody | Details |
| 2-Hydroxy-6-iodobenzoic acid | C7H5IO3 | 89677-81-6 | Details |
| CMV pp65 (495-503) (HLA-A2) | Details |
| Methyl 2-amino-3-fluoropropanoate hydrochloride | C4H9ClFNO2 | 136581-47-0 | Details |
| 1-(3-Fluorophenyl)-6-oxopiperidine-3-carboxylic acid | C12H12FNO3 | 1285045-55-7 | Details |
| 6-Chloro-6-defluoro ciprofloxacin-d8 | C17H18ClN3O3 | 93106-58-2 | Details |
| 3-Amino-2-[(4-fluorophenyl)methyl]propanamide | C10H13FN2O | 1038293-66-1 | Details |
| 4-Ethoxy-2-methylphenol | C9H12O2 | 84822-50-4 | Details |
| 2-[4-Bromo-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetic acid | C6H4BrF3N2O2 | 1006319-26-1 | Details |
| 2-Methoxy-3-methyl-pyridin-5-ol | C7H9NO2 | 1216253-16-5 | Details |
| N1-(4-Methoxypyrimidin-2-yl)benzene-1,4-diamine | 1343015-64-4 | Details |
| 2-(5-Bromopyridin-3-yl)ethan-1-ol | C7H8BrNO | 1255713-61-1 | Details |
| 4-(3,4-Difluorophenyl)-1,3-oxazol-2-amine hydrochloride | 2089256-09-5 | Details |
| RAB3IL1 antibody | Details |
| 3-Methoxy-5-(1H-pyrazol-1-yl)aniline | C10H11N3O | 1516412-41-1 | Details |
| 1,6-Naphthyridine-4-carboxylic acid hydrochloride | C9H7ClN2O2 | 1797032-00-8 | Details |
| 6-O-Benzoyl-3-O-tert-butyldimethylsilyl-D-galactal | C19H28O5Si | Details |
| 2-Chloro-N,N-bis(2-methoxyethyl)acetamide | C8H16ClNO3 | 10263-25-9 | Details |
| 2-(2-Bromopyridin-3-yl)acetic acid | C7H6BrNO2 | 1227578-15-5 | Details |
| Ganoderic acid S | C30H44O3 | 104759-35-5 | Details |
| trans 3-(N-Methylanilino)acrolein | C10H11NO | 34900-01-1 | Details |
| N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 500 ? | Details |
| 2.5-Dimethyl-4-hydroxy-3(2H)-furanone-b-D-glucoside-6'-malonate | C15H20O11 | 182236-12-0 | Details |
| H-LMGYIPLVGA-OH | Details |
| 2-(3,5-Dichlorophenoxy)-3-methoxypropanoic acid | 701915-91-5 | Details |
| 2-((2-phenylethyl)amino)pyridino[3,2-e]1,3-thiazin-4-one | C15H13N3OS | 1022651-97-3 | Details |
| SLC10A5 antibody | Details |
| NT5DC2 antibody | Details |
| LYPLA2 antibody | Details |
| 3-(2-Chloro-4-nitrophenyl)propanoic acid | C9H8ClNO4 | 501678-57-5 | Details |
| N,N-Dimethyl-4-(morpholin-2-yl)pyrimidin-2-amine | C10H16N4O | 1316218-43-5 | Details |
| DL-Coniine hydrobromide | C8H17N.BrH | 637-49-0 | Details |
| Forosamine | C8H17NO2 | 18423-27-3 | Details |
| COL8A2 Blocking Peptide | Details |
| 4-(2-methyl(8-quinolyloxy))-1-nitrobenzene | C16H12N2O3 | 1020252-26-9 | Details |
| Ethyl 2-{3-bromoimidazo[1,2-a]pyridin-2-yl}acetate | C11H11BrN2O2 | 2106254-15-1 | Details |
| 1-1(Z)-Hexadecenyl-2-palmitoyl-sn-glycero-3-pc | C40H80NO7P | 126901-45-9 | Details |
| N-(4-Hydroxy)benzyl o-tert-butyldimethylsilyl ractopamine | C31H43NO4Si | 1797883-87-4 | Details |
| Euphorbetin | C18H10O8 | 35897-99-5 | Details |
| Product Total： Product Page： | ||||
| 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 | ||||